Adalimumab Market Analysis - Forecast(2022 - 2027)

1
Adalimumab MarketMarket size, Industry outlook,
Market Forecast, Demand Analysis, Market Share,
Market Report 2021-2026
Contact Venkat Reddy sales_at_industryarc.com
(1) 970-236-3677
2
Download PDF Brochure

• Adalimumab Market Size is estimated to reach 5.1
  billion by 2027. Furthermore, it is poised to
  grow at a CAGR of 5.1 over the forecast period
  of 2022-2027. Adalimumab is a monoclonal antibody
  and disease-modifying antirheumatic medication
  that acts by inactivating tumor necrosis
  factor-alpha. It is marketed under the brand
  names Humira and Exemptia, among others. The
  original adalimumab drug is sold under the brand
  name Humira. New versions of adalimumab are known
  as adalimumab biosimilars. Biosimilars are
  similar versions of original biological
  medicines. 

Inquiry Before Buying
Email sales_at_industryarc.com
3
Download PDF Brochure

• Key Takeaways
• The growing prevalence of arthritis and skin
  disorders is estimated to drive the market growth
  of the Adalimumab Market. High cost as well as
  lack side effects of adalimumab poses threat to
  the market growth.
• A detailed analysis of strengths, weaknesses,
  opportunities, and threats will be provided in
  the Adalimumab Market Report.

Inquiry Before Buying
Email sales_at_industryarc.com
4
Download PDF Brochure
By Distribution Channel- Segment
Analysis Adalimumab Market based on the disease
can be further segmented into Crohns disease,
Psoriatic arthritis, Rheumatoid arthritis,
Ulcerative colitis, and others. Rheumatoid
arthritis held a dominant market share in the
year 2021 and is estimated to be
the fastest-growing, with a CAGR of 7.8 over the
forecast period of 2022-2027. Rheumatoid
arthritis is a chronic inflammatory disorder that
affects several joints, especially the hands and
feet. The immune system of the body targets its
own tissue, such as joints and muscles and
attacks the internal organs in extreme cases.
According to the estimations of the World Health
Organisation (WHO) in 2021, around 14 million
people live with Rheumatoid arthritis.
Inquiry Before Buying
Email sales_at_industryarc.com
5
Download PDF Brochure

• Cloud ERP Market Outlook
•  Croda International Plc
• AbbVie Inc
• Clariant AG
• Novartis AG
• AkzoNobel N.V
• F. Hoffmann-La Roche Ltd.
• Evonik Industries
• PolyOne Corporation
• DuPont
• Addcomp Holland

Inquiry Before Buying
Email sales_at_industryarc.com
6
Download PDF Brochure
Adalimumab Market Analysis -
Forecast(2022 - 2027) Learn More About the
Report _at_ https//www.industryarc.com/Report/152
76/adalimumab-market.html
Inquiry Before Buying
Email sales_at_industryarc.com
7
Download PDF Brochure

• You Can Customize the Report as Per Your Need.
  We have included Some Customization Options
• Company Profile
• Analyst Briefing
• Data Tables
• Key Contacts
• Free Customization
• Purchase Full Report _at_ https//www.industryarc.co
  m/purchasereport.php?id15276

Inquiry Before Buying
Email sales_at_industryarc.com
8
Download PDF Brochure
For More Details Contact Venkat
Reddy Contact (1) 970-236-3677 Email
sales_at_industryarc.com Connect with us on LinkedIn
_at_ http//www.linkedin.com/company/industryarc
Contact (1) 970-236-3677
Inquiry Before Buying
Email sales_at_industryarc.com